[HTML][HTML] SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

…, Y van der Meer, L Caly, J Druce… - Journal of General …, 2020 - microbiologyresearch.org
The sudden emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
at the end of 2019 from the Chinese province of Hubei and its subsequent pandemic spread …

[HTML][HTML] A new arenavirus in a cluster of fatal transplant-associated diseases

G Palacios, J Druce, L Du, T Tran, C Birch… - New England journal …, 2008 - Mass Medical Soc
Background Three patients who received visceral-organ transplants from a single donor on
the same day died of a febrile illness 4 to 6 weeks after transplantation. Culture, polymerase-…

Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers

ML Grayson, S Melvani, J Druce, IG Barr… - Clinical Infectious …, 2009 - academic.oup.com
Background . Although pandemic and avian influenza are known to be transmitted via
human hands, there are minimal data regarding the effectiveness of routine hand hygiene (HH) …

[HTML][HTML] Assessment of the analytical sensitivity of 10 lateral flow devices against the SARS-CoV-2 Omicron variant

J Deerain, J Druce, T Tran, M Batty… - Journal of Clinical …, 2022 - Am Soc Microbiol
Timely and accurate diagnostic testing is a critical component of the public health response
to coronavirus (CoV) disease 2019 (COVID-19). Antigen (Ag) tests are used widely in many …

Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002–2003

J Druce, T Tran, H Kelly, M Kaye… - Journal of medical …, 2005 - Wiley Online Library
Respiratory viruses were identified by the polymerase chain reaction (PCR) in more than
4,200 specimens collected during 2002 and 2003 in Victoria, Australia from patients admitted …

[HTML][HTML] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

L Caly, JD Druce, MG Catton, DA Jans, KM Wagstaff - Antiviral research, 2020 - Elsevier
Although several clinical trials are now underway to test possible therapies, the worldwide
response to the COVID-19 outbreak has been largely limited to monitoring/containment. We …

[HTML][HTML] Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

I Thevarajan, THO Nguyen, M Koutsakos, J Druce… - Nature medicine, 2020 - nature.com
To the Editor—We report the kinetics of immune responses in relation to clinical and virological
features of a patient with mild-to-moderate coronavirus disease 2019 (COVID-19) that …

[HTML][HTML] SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

…, LL Carter, A Cullinane, T De Oliveira, J Druce… - Nature …, 2021 - nature.com
A group convened and led by the Virus Evolution Working Group of the World Health
Organization reports on its deliberations and announces a naming scheme that will enable …

[HTML][HTML] Monkeypox infection presenting as genital rash, Australia, May 2022

…, G Papadakis, AA Sanchez, J Druce… - …, 2022 - eurosurveillance.org
Rapid diagnosis and whole genome sequencing confirmed a case of monkeypox in an HIV-positive
individual receiving antiretroviral therapy. The patient had a normal CD4+ T-cell …

Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia

L Caly, J Druce, J Roberts, K Bond… - Medical Journal of …, 2020 - Wiley Online Library
Objectives To describe the first isolation and sequencing of SARS ‐CoV‐2 in Australia and
rapid sharing of the isolate. Setting SARS ‐CoV‐2 was isolated from a 58‐year‐old man from …